Clinical Trial Update: Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee [Phase 3]

View source ↗

Summary

Phase 3 study assessing safety of repeat administration of FX006 in patients with osteoarthritis of the knee has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• FX006

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Osteoarthritis of the Knee | Phase 3 | Status: COMPLETED | Results posted: 2019-10-29